JP2022539400A5 - - Google Patents

Info

Publication number
JP2022539400A5
JP2022539400A5 JP2021578068A JP2021578068A JP2022539400A5 JP 2022539400 A5 JP2022539400 A5 JP 2022539400A5 JP 2021578068 A JP2021578068 A JP 2021578068A JP 2021578068 A JP2021578068 A JP 2021578068A JP 2022539400 A5 JP2022539400 A5 JP 2022539400A5
Authority
JP
Japan
Prior art keywords
methyl
bis
biphenyl
alkyl
pentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021578068A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022539400A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/050932 external-priority patent/WO2021000053A1/en
Publication of JP2022539400A publication Critical patent/JP2022539400A/ja
Publication of JP2022539400A5 publication Critical patent/JP2022539400A5/ja
Pending legal-status Critical Current

Links

JP2021578068A 2019-07-04 2020-07-03 カンナビノイド誘導体 Pending JP2022539400A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962870743P 2019-07-04 2019-07-04
US62/870,743 2019-07-04
US201962934318P 2019-11-12 2019-11-12
US62/934,318 2019-11-12
US202062966421P 2020-01-27 2020-01-27
US62/966,421 2020-01-27
PCT/CA2020/050932 WO2021000053A1 (en) 2019-07-04 2020-07-03 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2022539400A JP2022539400A (ja) 2022-09-08
JP2022539400A5 true JP2022539400A5 (enExample) 2023-07-10

Family

ID=74100116

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021578068A Pending JP2022539400A (ja) 2019-07-04 2020-07-03 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US20220267239A1 (enExample)
EP (1) EP3994114A4 (enExample)
JP (1) JP2022539400A (enExample)
WO (1) WO2021000053A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
US12252503B2 (en) 2019-07-12 2025-03-18 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021102567A1 (en) 2019-11-26 2021-06-03 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US12240813B2 (en) 2020-05-19 2025-03-04 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
EP4243774A4 (en) * 2020-11-16 2024-11-06 Synergy Life Science, Inc. Cannabinoid emulsifier
CN112898190B (zh) * 2021-02-07 2023-10-24 中国科学院长春应用化学研究所 一种大麻二酚衍生物及其制备方法
TWI894435B (zh) * 2021-02-26 2025-08-21 日商丸善石油化學股份有限公司 縮醛化合物、含有該化合物之添加劑及含有該化合物之阻劑用組成物
CN113149897B (zh) * 2021-03-24 2023-10-31 福建省中科生物股份有限公司 一种2,6-取代-4-氧基萜酚吡啶类化合物及其制备方法和用途
CN113087661B (zh) * 2021-03-24 2022-09-06 福建省中科生物股份有限公司 一种2’，6’-双吡啶取代大麻二酚醚类化合物及其制备方法和用途
WO2022213931A1 (zh) * 2021-04-06 2022-10-13 山东绿叶制药有限公司 大麻二酚前药及其药物组合物和应用
CA3227884A1 (en) * 2021-08-04 2023-02-09 John Crawford Cannabinoid derivatives and their use
CN116253671B (zh) * 2021-12-10 2025-07-04 德义制药有限公司 一种大麻二酚衍生物及其制备方法和应用
KR20250116719A (ko) * 2022-12-02 2025-08-01 베네테라 (샤오싱) 바이오테크놀로지 코., 엘티디. 화합물 및 Treg 관련 질환의 치료에서의 이의 응용
WO2026038872A1 (ko) * 2024-08-13 2026-02-19 주식회사 네오켄바이오 신규한 화합물 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643366A1 (de) * 1967-10-04 1971-06-09 Bayer Ag Verfahren zur Herstellung von Phenol-Halbformalen
DE3306201A1 (de) * 1983-02-23 1984-08-23 Bayer Ag, 5090 Leverkusen Mittel zur regulierung des pflanzenwachstums
US6566560B2 (en) * 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
PT2473475T (pt) * 2009-08-31 2017-08-02 Zynerba Pharmaceuticals Inc Utilização de profármacos de canabidiol na administração tópica e transdérmica com microagulhas
KR102202133B1 (ko) * 2016-01-29 2021-01-14 더 유니버시티 오브 미시시피 생물학적으로 활성인 칸나비디올 유사체
AU2017250303B2 (en) * 2016-04-15 2019-09-26 Teewinot Technologies Limited Biosynthesis of cannabinoid prodrugs
BR112018071518A2 (pt) * 2016-04-22 2019-02-19 Receptor Life Sciences, Inc. compostos medicinais à base de planta de ação rápida e suplementos nutricionais
JP2018162231A (ja) * 2017-03-27 2018-10-18 三井化学株式会社 遷移金属化合物、オレフィン重合用触媒およびオレフィン系重合体の製造方法

Similar Documents

Publication Publication Date Title
JP2022539400A5 (enExample)
JP2023505513A5 (enExample)
JP2022540432A5 (enExample)
JP2022540585A5 (enExample)
JP2022540434A5 (enExample)
JP2022551067A5 (enExample)
JP2022539401A5 (enExample)
JP2023503601A5 (enExample)
CN113365997A (zh) 作为c-Met抑制剂的含嘧啶基团的三并环类化合物
JP2022551066A5 (enExample)
JP2022540586A5 (enExample)
PE20211788A1 (es) Compuesto agonista de receptor thrb y metodo de preparacion y uso del mismo
RU2341515C2 (ru) Ацетиленовые производные, способ их получения, фармацевтическая композиция на их основе и их применение в качестве антагонистов метаботропных глутаматных рецепторов (mglur5)
TWI454453B (zh) 用於合成苯并茚前列腺素之中間物及其製備方法
JP2023503330A5 (enExample)
JP2023503331A5 (enExample)
JP2015516420A5 (enExample)
IL287159B1 (en) Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use
AR074184A1 (es) Compuestos de 7-azaspiro[3.5]nonano-7-carboxamida, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de afecciones mediadas por la inhibicion de faah
NL1028087C2 (nl) Sulfonamiderivaten voor de behandeling van ziekten.
JP6813626B2 (ja) グルコシルセラミド合成酵素阻害剤の製造方法
JP2016515096A5 (enExample)
SK284068B6 (sk) Ester odvodený od substituovanej fenylcyklohexylovej zlúčeniny, spôsob jeho prípravy a použitie
JP7422737B2 (ja) 神経変性疾患を治療するためのＰｐａｒｇｃ１ａ活性化剤としての２‐アリールベンゾイミダゾール
JP2021515004A5 (enExample)